Evidence map›Paper›PMID 40542625›Full record

ReviewJournal of neuroendocrinology2025

Thyroid lesions of neuroendocrine origin? Thinking of a "polka-dotted" zebra! Case series from three Italian referral centers and review of the literature.

Tiziana Feola, Alessia Cozzolino, Federica Grillo, Maria Francesca Birtolo, Irene Aini, Erika Messina, Roberto Minotta, Alessia Filice, Isabella Zanata, Paola Razzore and 6 more

Abstract readReviewCase ReportsMulticenter Study
In one paragraph

Review in Journal of neuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tiziana FeolaDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.ORCID 0000-0003-1066-0064
Alessia CozzolinoDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.ORCID 0000-0001-8614-5873
Federica GrilloAnatomic Pathology Unit, University of Genova and Policlinico San Martino Hospital, Genoa, Italy.ORCID 0000-0001-6477-3182
Maria Francesca BirtoloEndocrinology, Diabetology and Medical Andrology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.ORCID 0000-0001-8100-8394
Irene AiniEndocrinology Unit, Azienda Ospedaliera Universitaria Sassari, Sassari, Italy.ORCID 0009-0004-3430-0340
Erika MessinaDepartment of Clinical and Biological Sciences, Internal Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.ORCID 0009-0008-9981-3314
Roberto MinottaDepartment of Clinical Medicine and Surgery, Endocrinology, Diabetology and Andrology Unit, Federico II University of Naples, Naples, Italy.ORCID 0000-0002-8823-0702
Alessia FiliceDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.ORCID 0009-0001-8339-5591
Isabella ZanataDepartment of Medical Sciences, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy.
Paola RazzoreEndocrinology Unit, Mauriziano Hospital, Turin, Italy.ORCID 0000-0001-9086-6614
Manila RubinoDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Andrea M IsidoriDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.ORCID 0000-0002-9037-5417
Annamaria ColaoDepartment of Clinical Medicine and Surgery, Endocrinology, Diabetology and Andrology Unit, Federico II University of Naples, Naples, Italy.ORCID 0000-0003-4049-2559
Antongiulio FaggianoEndocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-9324-3946
Elisa GiannettaDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.ORCID 0000-0003-3614-6151
NIKE group

Funding

European Union - Next Generation EU ECS 00000024 CUP: B83C22002820006
6 · The paper itself

Abstract

backgroundNeuroendocrine neoplasms (NENs) may metastasize very rarely to the thyroid. The current paper aims at identifying peculiar thyroid nodule's features that could prompt their diagnosis and analyzing therapeutic approach and patient's outcome. MATERIALS AND

methodsA case series of three patients have been collected from three Italian referral centers. Moreover, we performed a keyword based PUBMED search, using relevant keywords.

resultsWe included in the review 27 papers and 33 cases have been identified. Patients' age ranged from 17 to 85 years (mean age: 55.8 ± 14.2 years), 14 males, 42.4%. The majority of cases (48.5%) originated from a thoracic NEN. Median time to diagnosis from the primary tumor was 48 months (range 1-252 months). At ultrasound, they were generally hypoechoic nodules with irregular margins. The diagnosis was made by fine-niddle aspiration in the majority of cases, followed by nuclear medicine imaging. At immunohistochemistry, chromogranin A and synaptophysin were expressed in almost all of them, with negative calcitonin and thyroid transcription factor-1. Surgery or systemic treatment were needed according to primary tumor, disease stage, and patients' general condition. Prognosis was variable, better if primary tumor origin was thoracic.

conclusionsThyroid metastases from NENs should be considered in the diagnostic work-up of suspicious thyroid nodules in patients with a positive medical history of previous NEN, mainly of thoracic origin. Immunohistochemistry is the key diagnostic tool for their identification. A prompt and correct diagnosis is mandatory because of its crucial prognostic and therapeutic implications.

Indexed as

Neuroendocrine TumorsThyroid NeoplasmsThyroid NoduleAdolescentAdultAgedAged, 80 and overFemaleHumansItalyMaleMiddle AgedYoung Adultmedullary thyroid carcinomaneuroendocrine neoplasmsneuronendocrine tumorsthyroid metastasesthyroid tumors

Identifiers

PMID40542625
PMCPMC12404902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.